SunCoast Blood Bank
1760 Mound St
Sarasota FL 34236
Mission

SunCoast Blood Bank provides a reliable supply of quality blood products and services to hospitals and health centers in need.

Leadership
CEO/Executive Director Mr. Scott M. Bush
Board Chair Admiral, Ret. Steve Branham
Board Chair Affiliation retired
General Info
Organization DBA
DBA
0
0
0
Former Names
Sarasota Community Blood Bank
Suncoast Communities Blood Bank
Lower West Coast Blood Bank
Tax Exempt Status Public Supported Charity
Incorporation Year 1969
Awarded competitive grant from Community Foundation in the last 5 years? Yes
State Charitable Solicitations Permit Yes May 2017
State Registration Yes Dec 2016
Financial Summary
 
 
Projected Revenue $13,715,623.00
Projected Expenses $13,564,255.00
IRS Letter of Determination
IRS Determination LetterView
Other Documents
AABB Certificate for Accrediation of Donor Center ActivitiesView
AABB Accrediation for Transfusion ActivitiesView
State of Florida Clinical Laboratory LicenseView
FDA Blood Bank RegistrationView
FDA Registration for Collection and Distribution For Human Cells, Tissues, and Cellular and Tissue-Based ProductsView
Impact Statement

Accomplishments

  1.  When Zika was confirmed in South Florida, SunCoast knew it was only a matter of time before local travel-related, as well as locally contracted cases would appear in our community.  SunCoast immediately began preparing to test all blood and platelets for the virus. Because blood banks are so highly regulated by the FDA, introducing a new test is a very complicated and involved process.  SunCoast was ready one week prior to the FDA making the test mandatory.  Other blood banks in the state were not as prepared and were ordered to cease all collections until they could test.  Because SunCoast was ready, we were able to assist those blood banks with vital products during the days they were shut down.
  2. Thanks to a $150,000 grant, SunCoast was able to replace its 10-year-old Blood Establishment Computer System (BECS).  A BECS is technology mandated by the FDA and only a limited number of companies are approved by the FDA to supply the system.  A BECS is the nerve system of a blood bank as it traces every touch point of the product from the time a donor presents to the time the unit is transfused.
  3. SunCoast was able to aid the Pulse shooting victims by shipping O negative blood (the universal donor type) to Orlando hospitals within 24 hours of the shooting.
  4. SunCoast awarded $25,000 in scholarships to high school seniors who donated three time during their senior year.
  5. SunCoast received seven of 13 Awards of Excellence presented by our national organization, America's Blood Centers.

Goals

  1.  Implement the new BECS software.  The Information Technology Team began working on the platform in November.  Because it is a highly technical program that touches virtually every aspect of the day-to-day operations of the blood bank implementation takes a minimum of nine months.  A process must be developed for over 600 Standard Operating Procedures, trials and trouble shooting must be conducted and staff must be trained.  The goal is for the system to "go live" by the end of the summer.
  2. Because less than 4% of the population donates 100% of the blood supply, and LESS than 1%, 100% of the platelets, we must make donating as convenient as possible.  That means taking our bloodmobiles to businesses, events and neighborhoods.  The average age of our fleet is 25 years old and the last bloodmobile was purchased almost six years ago. Two had to be retired in the last few years due to their age. With the addition of SMH's Level 2 Trauma Center, their new campus in Venice and their new destination cancer treatment center, SunCoast must begin to prepare now, for a dramatic increase in need for blood products.  We must purchase a new bloodmobile in 2018 to accommodate SMH's needs when these new facilities are projected to open between 2019 and 2020.
  3. Due to the projected demands for blood products, and the maxed out status of our main bricks and mortar facility, the board and staff must enter into a research and development phase this year to determine if the existing facilities are sufficient.
 
 
Needs Statement
  1. SunCoast must purchase a new bloodmobile in 2018, at the cost of $300,000 for a fully equipped vehicle, including the technology.
  2. SunCoast continues reviewing its physical plant and assessing its brick and mortar needs.   With the addition and expansion of programs at Sarasota Memorial Hospital, including the trauma center, and a cancer treatment center SunCoast must stay abreast of the community needs for blood products and the ability to house all of its operations.
  3. The need to update technology is constant and expensive.  Blood banks are considered a pharmaceutical manufacturer and are highly regulated by the FDA. The FDA mandates certain upgrades and processes and the blood bank must keep up with their requirements. Therefore, once again, development is playing a greater role in the ability the purchase new technology that often exceeds our ability to pay. 
Background Statement
For 68 years, SunCoast Blood Bank (SCBB), has been the sole provider of safe and reliable blood products and services to communities in Southwest Florida. SunCoast also provides transfusion services at several local hospitals. The most common need arises from cancer patients, trauma patients, and surgical patients.  The most vulnerable patients are newborns in crisis needing blood or platelets. SCBB provides a wide range of blood services and medically-ordered therapeutic blood procedures to outpatients and inpatients throughout the region.  SunCoast Blood Bank provides 24/7 care 365 day of the year.
 
SCBB needs an average of 150 units of blood a day to meet the needs of our local hospitals and healthcare facilities. Meeting that requirement is becoming more challenging.  Less than 4% of the United States population donates blood.  Many of our most loyal blood donors, members of the “greatest generation” are no longer able to give. At the same time, the FDA is enforcing tougher safety standards disqualifying a large population of younger potential donors.
 
SunCoast Blood Bank operates five donor centers and conducts over 1,300 mobile blood drives a year. Blood drives are held at schools, businesses, community centers and places of worship seven days a week and account for 60% of all blood collection. By 2019 we expect that 70-80% of all blood products will be collected on bloodmobiles.
Areas Served
Areas Served
Area
FL- Charlotte
FL- DeSoto
FL- Manatee
FL- Sarasota
Areas Served Comments
  • Sarasota - all zip codes
  • Bradenton
  • Lakewood Ranch
  • Arcadia
  • Englewood
  • North Port
  • Port Charlotte
  • Punta Gorda
  • Venice
  • Osprey
Service Categories
Primary Org Type Health Care
Secondary Org Type Health Care
Tertiary Org Type
Statement from the Board Chair/Board President

I am proud to help forward the mission of SunCoast Blood Bank, to provide a reliable supply of quality blood products and services to hospitals and health centers in need. Thanks to the support of local foundations, businesses, media, civic organizations, individual financial donors, and most of all, our loyal blood donors, SunCoast is stronger than ever. Thanks to the generosity of our community, we were able to replace our 10-year-old Blood Establishment Computer System last year. It is a privilege to serve our community and contribute to its well-being, however, it is also a tremendous responsibility.  We must have the right blood products on our hospital shelves at the right time for patients in crisis.  As these demands increase, we must revisit our ability to serve by conducting a thorough assessment of the state of our bricks and mortar, technology and equipment necessary to keep the blood supply safe and available for our community.

Rear Admiral Steve Branham, USCG (retired)
Statement from the CEO/Executive Director

SunCoast Blood Bank (SCBB) was founded in 1949 as the Lower West Coast Blood Bank. Our tagline "Live here. Give here. Stays here," embodies our purpose. Although the name has changed, our mission to remain a local, independent blood center, providing quality blood products to community hospitals, remains strong. Not only has SCBB prevailed in the unprecedented number of blood bank consolidations in the industry, it has flourished.

I am proud to report that in 2016 we became the first blood bank in the country to implement the INTERCEPT pathogen reduction technology. Emerging "bugs" such as Zika, dengue and Chikungunya can be completely removed from platelets via this technology. This is significant because Zika and dengue has become prevalent in Florida and Texas. Of the 3,900 lab confirmed cases of Chikungunya, 11 were in the US, and all 11 were in Florida. If these bugs became an epidemic in the region, it would force the cessation of blood collections, mandating that all blood products be imported, at a tremendous expense to the cost of healthcare. As the Zika virus continues to proliferate in the state of Florida, this technology will prove to be a critical resource for our community, and possibly others blood banks that do not yet have the technology.
 
With excellent management, superior technology and dedicated staff, another key to our success is a strong local presence. Unlike other mega blood centers, our structure is totally community based. As a CEO living in the community we serve, with a local board, I am able to move quickly and efficiently to serve the needs of the hospitals and health care providers we work with.

SCBB is grateful for the tremendous support it receives from our community. Our blood donors and our financial donors are the backbone of our organization. We strive each day to be the best, because lives depend on it.
 
Scott Bush, CEO 
Programs
Description

A collaboration with Sarasota Memorial Hospital and Florida Cancer Specialists & Research Institute has enabled SunCoast Blood Bank to participate in groundbreaking cellular therapy (MNC) for patients undergoing ovarian and prostate cancer treatments.

With the ovarian cancer therapy still in the clinical study phase, the prostate cancer program is FDA approved and currently active in many centers across the US.

MNC is an alternative treatment for stage-four prostate cancer patients which utilizes an individual’s own white blood cells to boost his own immune system. The therapy requires the extraction of dendritic cells which are sent to a lab for processing. These are then returned to be re-infused into the patient in the form of a vaccine designed to seek and attack prostate cancer cells. By stimulating the natural ability of immune cells already in the patient’s body, this therapy helps fight advanced prostate cancer.
Budget $180,000
Category Medical Research, General/Other Cancer Research
Program Linked to Organizational Strategy Yes
Population Served Adults Males Adults
Short Term Success

MNC therapy is a rapidly growing and active field as more and more laboratories are finding ways to treat cancer.  Given the time required by each procedure and the regimen of treatments ordered for each patient, it is imperative that patients have access to a local provider of this service. Local patients undergoing prostate cancer treatment that require the MNC procedure no longer have to leave the comfort of their own community to receive care in larger centers.  With the expansion of our services to implement our own therapy center, local patients will have the option to be treated locally by an approved, regulated and suitably prepared institution.

Long Term Success

Only licensed and properly equipped institutions can perform this procedure and SunCoast Blood Bank has the expertise and trained staff to offer this service to our community. MNC therapy is gaining momentum as a plan of treatment as more and more laboratories are finding ways to treat cancer.

Program Success Monitoring

Patients currently undergoing MNC therapy for stage-four prostate cancer are under the supervision of their local oncologist. SCBB works closely with their medical providers during their treatment.

In a clinical trial that supported FDA approval, more men treated with MNC lived longer than men not using same procedure. More men in the same treatment group were alive 3 years after the start of the study than men not treated with the vaccine. The vaccine reduced the risk of death by 22.5% for patients in the treatment group and only 1.5% of men discontinued treatment due to side effects.

Program Success Examples

MNC is an immunotherapy of autologous dendritic cells re-infused into the patient consisting of prostatic acid phosphatase (PAP) linked to granulocyte-macrophage colony-stimulating factor. Sequential phase I and phase II trials were performed to determine the safety and efficacy of the vaccine and to assess its capacity to break. Reports from vaccine manufacturer shows that patients tolerated treatment well. Fever, the most common adverse event, occurred after 15 infusions (14.7%). All patients developed immune responses to the fusion protein used to prepare the vaccine, and 38% developed immune responses to PAP. Three patients had a more than 50% decline in prostate-specific antigen (PSA) level, and another three patients had 25% to 49% decreases in PSA. The time to disease progression correlated with development of an immune response to PAP and with the dose of dendritic cells received immune tolerance to the normal tissue antigen PAP.

Description
The Generation Give Scholarship Program was established in 2006. Studies show that students who begin donating in high school are likely to become life-long donors. The Generation Give program was established to motivate students to donate, thus beginning a life-long service to their community. As the economy began to struggle, the need for financial assistance to obtain the dream of a college education became greater, making SCBB's scholarship program a win-win situation. Students experience first-hand the opportunity to commit a life-saving act, and in turn they are eligible to receive a partial scholarship towards college tuition.
 
To be eligible, a student must donate blood or platelets three times during their senior year or demonstrate support of the SCBB mission by volunteering at least 26 hours their senior year. This can be done by promoting school blood drives, volunteering for SCBB or acting as a "Blood Buddy" during their graduation year. (Blood Buddy is a student volunteer who helps out on the days of the drive). Upon successfully completing these requirements, the student may apply for a scholarship, which if awarded, is paid directly to the college or university.
Budget $20,000
Category Education, General/Other Education, General/Other
Program Linked to Organizational Strategy Yes
Population Served Other Named Groups Other Named Groups Other Named Groups
Short Term Success

Students now account for 25% of total blood donated in our community.  As we face an on-going decrease in the population of adult donors, it is imperative that we continue reaching out to our youth to emphasize the importance of blood donation and the impact they are making in other people's lives by becoming a blood donor.

Long Term Success

National studies show that adolescents who donate blood at least three times are most likely to become life-long blood donors.  Cultivating the next generation of blood donors is one step closer to assure that demand for blood will not exceed supply - an ongoing threat faced by all blood banks.

Program Success Monitoring

Community volunteers and SCBB staff comprise a committee to establish guidelines and to review each scholarship application. As part of the application process, students are asked to evaluate several key areas that helps SCBB determine what best motivates students to become blood donors.

Program Success Examples

SCBB has distributed over $124,000 in college scholarships since the creation of the program. In 2014, 54 high school seniors were awarded more than $24,000 in scholarships. SCBB maintains an extensive database that allows us to track donors. The data indicates that many of our young adult donors, began giving blood in high school.

Description

SunCoast has taken steps to make the blood supply even safer by being the first blood bank in the country to acquire the INTERCEPT Blood System for platelets and plasma. This revolutionary technology significantly reduces the risk of transfusion-transmitted pathogens such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria, and dengue. Platelets are vital in the treatment of cancer patients, who are also the most vulnerable to fatal complications caused by pathogens. Platelets contaminated with bacteria remain one of the highest causes of transfusion-related mortality, and Pathogen Reduction will  dramatically improve patient outcomes in our community.

Cerus created a molecule called amotosalen which is filtered into the platelets and binds itself to DNA and RNA. The unit of platelets is then placed under a UV light which envelopes the pathogens which are then filtered out.

Budget $50,000
Category Health Care, General/Other Blood Banking
Program Linked to Organizational Strategy Yes
Population Served Adults Children and Youth (0 - 19 years) Aging, Elderly, Senior Citizens
Short Term Success
Because platelets contaminated with bacteria remain one of the highest causes of transfusion-related mortality, and Pathogen Reduction will dramatically reduce this possibility and improve patient outcomes in our community. An added benefit of the technology is that platelets can be released earlier after testing. Because they must be stored at room temperature, platelets are only good for five days. INTERCEPT can increase platelet effective shelf life by as much as half a day. This is significant since less than one percent of the population donates 100 percent of this vital blood product.
 
Emerging "bugs" such as dengue and Chikungunya can be completely removed from platelets via this technology. This is significant because dengue has become prevalent in Florida and Texas. Of the 3,900 lab confirmed cases of Chikungunya, 11 were in the US, and all 11 were in Florida. If these bugs became an epidemic in the region, it would force the cessation of blood collections.
Long Term Success Currently the technology is only approved for platelets.  The blood banking industry is hopeful that the FDA will approve the technology for red cells.  This would enhance the safety of the blood supply on an entirely new level.
Program Success Monitoring The community should see a significant reduction in the number of bacteria-related complications.
Program Success Examples

The most relevant example is the use of the technology to combat the Ebola epidemic. Cerus was part of the team that went to West Africa as part of the Gates Foundation initiative to combat Ebola. Their INTERCEPT Blood System, was used to manufacture convalescent plasma to treat patients. The same technology was used for Ebola patients transferred to the United States for treatment.

Comments
Program Comments by Organization
The biggest challenge continues to be containing the cost of collecting, testing, storing and transfusing blood products.  Hospitals are under pressure to keep the cost of healthcare in line and this filters down to the blood bank.  SunCoast has one of the leanest operations in the country due to its efficient operations and skilled staff. Most of the blood bank's associated technology is mandated by the FDA and is constantly evolving, improving and emerging.  SunCoast must rely on voluntary financial contributions to cover the cost of the technology required to keep the blood supply safe and available.
 
Another challenge continues to be the shrinking donor pool.  In order to attract and retain donors, SunCoast is streamlining its donor rewards program by partnering with local businesses to offer gift cards at a significant discount. Every third donation, the donor will earn a $25 gift card from a local business. SCBB has also increased its visibility by partnering with local media outlets.
 
Scott Bush, CEO 
CEO/Executive Director
CEO/Executive Director Mr. Scott M. Bush
CEO Term Start Aug 2011
CEO/Executive Director Email sbush@scbb.org
Experience

Scott has over 20 years of experience in blood banking and joined SCBB in 2005 as Director of Donor Services and Recruitment. Most recently, Bush served as Chief Operating Officer, overseeing SCBB’s expansion into Manatee and Charlotte counties.  During his employment at SCBB, Bush was recognized as a Top 40 Under 40 by the Gulf Coast Business Review in 2009 and also was awarded Executive of the Year by the Florida Association of Blood Banks in 2008. Prior to joining SCBB, Bush worked with the American Red Cross for 15 years overseeing various departments within their biomedical service operation.  Bush also served in the United States Naval Reserve where he received the Navy Medal of Achievement.
Scott is a graduate of Ohio Dominican University and earned his masters degree in non-profit management from University of Central Florida. He resides in Parrish.

Former CEOs/Executive Directors
NameTerm
Mr. Kevin Lindberg Dec 2010 - Aug 2011
Dr. Mark J. Magenheim May 2003 - Dec 2010
Senior Staff
NameTitle
Mr. Mike Buell Director of Product Manufacturing
Mr. Christopher Ebert Information Technology Director
Mrs. Jayne Giroux Director of Community Development
Mr. John Hall Chief of Donor Services
Mr. Robert Harper Director of Quality Assurance
Mrs. Karen Hoder Accounting Supervisor
Mr. Rei Lopez Chief of Laboratory Services
Ms. Laura Williams Dircetor of Human Resources
Staff & Volunteer Statistics
Full Time Staff 78
Part Time Staff 34
Staff Retention Rate % 71
Professional Development Yes
Contractors 0
Volunteers 75
Management Reports to Board Yes
CEO/Executive Director Formal Evaluation Yes
Senior Management Formal Evaluation Yes
Non-Management Formal Evaluation Yes
Collaborations
  • Alliance for Community Transfusion Services
  • Blood Centers of America
  • Florida Cancer Specialists & Research Institute
  • Sarasota Memorial Hospital
  • Manasota Operation Troop Support
  • Manatee Memorial Hospital Foundation
  • Wildlife Rescue
  • Friendship Center
  • Cat Depot
  • Child Advocacy Center
  • Safe Place and Rape Crisis Center
  • Meals on Wheels
Affiliations
AffiliationYear
2000
2000
America Blood Centers2000
American Association of Blood Centers (AABB)2000
Englewood-Cape Haze Area Chamber of Commerce2012
Florida Association of Blood Banks (FABB)
Greater Sarasota Chamber of Commerce2000
Venice Area Chamber of Commerce2000
External Assessments and Accreditations
Assessment/AccreditationYear
State of Florida Clinical Laboratory License2013
AABB Transfusion Activities Accreditation2015
College of American Pathologists
FDA Blood Bank Registration2015
AABB Donor Center Activities2016
Clinical Lab Improvement Amendments Accreditation2015
FDA Registration for Collection and Distribution2015
Awards & Recognition
Award/RecognitionOrganizationYear
Dorothy M. Hansen Admnistrator of the YearFlorida Association of Blood Banks2011
Most Creative Donor Center EventFlorida Association of Blood Banks2013
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2013
The Most Creative Donor Center AwardFlorida Association of Blood Banks2012
Board Memeber of the Year - Maggie VeenemanFlorida Association of Blood Banks2012
Media of the Year Award - WSRZ 107.9America's Blood Centers2012
High School Achievement Award for a Mid-Size School - Sarasota Military AcademyFlorida Association of Blood Banks2012
Overall Most Productive Blood Drive - WSRZ 107.9Florida Association of Blood Banks2013
Media Partnership of the Year- WWSB ABC 7Florida Association of Blood Banks2013
Dorothy C Smith R.N. Award - John HorneFlorida Association of Blood Banks2014
Hospital Donor Group Achievement Award - Fawcett Memorial HospitalFlorida Association of Blood Banks2014
Hospital Partnership Award - Sarasota Memorial HospitalFlorida Association of Blood Banks2014
Donor Chairperson of the Year - Leslie CollierFlorida Association of Blood Banks2014
High School Achievement Award for Highest Participation of Mid-Sized Schools - Desoto High SchoolFlorida Association of Blood Banks2014
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2015
ITxM Award for Excellence in Technical OperationsAmerica's Blood Centers2015
Outstanding Humanitarian Service AwardAmerica's Blood Centers2015
Board Member of the Year - Mary Ann LeglerFlorida Association of Blood Banks2015
Most Creative Donor Center AwardFlorida Association of Blood Banks2015
Media Partnership Service AwardFlorida Association of Blood Banks2015
Innovation AwardFlorida Association of Blood Banks2015
Hopsital Medical Professional Advocate of the Year AwardFlorida Association of Blood Banks2015
Dorothy M. Hansen Executive of the Year Award - Jason CarneyFlorida Association of Blood Banks2015
High School Achievement Award for Highest Participation of Large-Sized Schools - Manatee High SchoolFlorida Association of Blood Banks2015
High School Achievement Award for Most Donations of Large-Sized Schools - Manatee High School2015
Finalist - Champions of Healthcare AwardsManatee Chamber of Commerce2015
Finalist - Healtcare/Wellness Organization of the Year Small Business AwardsSarasota Chamber of Commerce2015
ITxM Award for Excellence in Technical OperationsAmerica's Blood Centers2016
Terumo BCT Award of ExcellenceAmerica's Blood Centers2016
Healthcare Organization of the YearSarasota Chamber of Commerce2015
Corporate Partnership of the YearAmerica's Blood Centers2016
Blood Drive Achievement AwardAmerica's Blood Centers2016
7 Who Care Award of SupportWWSB ABC &2015
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2016
Corporate PartnershipAmerica's Blood Centers2016
Most Productive Blood DriveAmerica's Blood Centers2016
Most Creative Blood DriveAmerica's Blood Centers2016
ITxM AwardAmerica's Blood Centers2016
Risk Management Provisions
Automobile Insurance and Umbrella or Excess Insurance
Accident and Injury Coverage
Builders Risk
Commercial General Liability
Computer Equipment and Software
Disability Insurance
Employee Dishonesty
Fiduciary Liability
Flood
General Property Coverage
Life Insurance
Medical Health Insurance
Professional Liability
Workers Compensation and Employers' Liability
Government Licenses
Organization Licensed by the Government Yes
Plans
Fundraising Plan No
Communication Plan Yes
Strategic Plan No
Strategic Plan Years 2
Strategic Plan Adopted Sept 2013
Management Succession Plan No
Continuity of Operations Plan No
Policies
Nondiscrimination Policy Yes
Whistle Blower Policy Yes
Document Destruction Policy Yes
Directors and Officers Insurance Policy No
Policies and Procedures Yes
Comments
Management Comments by Organization
SCBB is fortunate to have a staff of dedicated employees committed to our mission.  The senior staff each oversee a pivotal portion of our operation and are experts in their fields.
 
The constant struggle of a blood bank is managing costs and recruiting new donors.  Because competitors offer sizable incentives to their donors, SunCoast  has made it a goal to appeal to the donors' sense of duty. It has done so through marketing campaigns, social media, and one-on-one interaction with donors. The implementation of a donor rewards store has cut down significantly on the cost of incentives. Donors accumulate points each time they give a donation and can retrieve items such as gift cards, books etc. from the store. Many of these items are donated. In addition, the donor has the option to forfeit their points and contribute to the high school scholarship program. Many donors elect this option. This tells us that our efforts to appeal to donors sense of pride in donating is becoming more and more successful.
Scott Bush, CEO 
Multi-Media Comments by Organization
SunCoast Blood Bank actively utilizes its media channels to fulfill the following needs:
  • Community awareness
  • Donor recruitment and retention
  • Donor communication
  • Fundraising
  • Promotions
  • Blood drives schedule and locations
  • Urgent and critcal shortage messaging
Other Documents
Other Document 2
Donor Recruitment
Board Chair
Board Chair Admiral, Ret. Steve Branham
Company Affiliation retired
Board Term Nov 2015 to Oct 2018
Board Chair Email jslaor@aol.com
Board Members
Board Members
NameAffiliation
Admiral, Ret Steve Branham Retired
Mr. William Dooley Dooley Mack
Mr. Chris Gray Community Volunteer
Mrs. Kathleen Hargreaves Kerkering Barberio
Mr. Ben Hatcher Capstan Financial Group
Mrs. Mary Ann Legler Manatee County School Board
Mr. Jeffery Reynolds Retired
Mrs. Kristine Russell Community Volunteer
Mr Ross Russo Swift Construction
Mr. Craig Tuley SunTrust
Mr. Juan Villavaces Attorney
Constituency Includes Client Representation No
Board Ethnicity
African American/Black 0
Asian American/Pacific Islander 0
Caucasian 10
Hispanic/Latino 1
Native American/American Indian 0
Other 0 0
Board Gender
Male 8
Female 3
Unspecified 0
Governance
Board Term Lengths 3
Board Term Limits 3
Board Orientation Yes
Number of Full Board Meetings Annually 8
Board Meeting Attendance % 71
Board Self-Evaluation Yes
Written Board Selection Criteria No
Board Conflict of Interest Policy Yes
% of Board Making Monetary Contributions 100
% of Board Making In-Kind Contributions 20
Standing Committees
Audit
Board Development / Board Orientation
Board Governance
Finance
Human Resources / Personnel
Strategic Planning / Strategic Direction
Development / Fund Development / Fund Raising / Grant Writing / Major Gifts
Comments
Governance Comments by Organization
Unlike large blood bank conglomerates, the SunCoast Board of Directors plays a pivotal role in the direction of the organization.  Blood banking is a highly regulated, technical institution and it takes more time than is traditional for board members to feel comfortable in their decision making role.  They must understand the technology and the operational needs in order to make informed decisions about capital items as well as policies.  For this reason, term limits are longer than you might see with other nonprofits. 
 
Greater emphasis has been on fund development and the role of the board. Therefore, SunCoast now seeks board members with the willingness and aptitude to immerse themselves in this process. When new board members are vetted, the expectation of their participation is clearly spelled out.
 
Staff has worked closely with the board to establish realistic fundraising goals for which each board member is responsible.  As was suggested in the Fundraising Toolkit workshop facilitated by John Elbare, each board member completed a personal plan for fundraising. Members are given the option of raising funds through hard credits (writing a check) or soft credits (recruiting a financial donor, securing auction items etc.). Staff has created several avenues for board members to raise funds, to match to their comfort level. At the end of the fiscal year, individuals are given a report card to see where their contributions stand.  In addition, development is a prominent part of each board meeting.  
 
Scott Bush, CEO 
Fiscal Year Projections
Fiscal Year Begins 2016
Fiscal Year Ends 2017
Projected Revenue $13,715,623.00
Projected Expenses $13,564,255.00
Total Projected Revenue includes "in-kind" contributions/ donations Yes
Organization has Endowment No
Endowment Spending Policy N/A
Capital Campaign
Currently In a Capital Campaign Yes
Anticipate Campaign within 5 years? Yes
Campaign Purpose Purchase a fully equipped bloodmobile.
Campaign Goal $300,000.00
Campaign Dates Oct 2016 to Sept 2017
Amount Raised To Date 99243 as of 0
Historical Financial Review
Revenue SourcesHelpThe financial analysis involves a comparison of the IRS Form 990 and the audit report (when available) and revenue sources may not sum to total based on reconciliation differences. Revenue from foundations and corporations may include individual contributions when not itemized separately.
Fiscal Year201620152014
Foundation and
Corporation Contributions
$0$0$0
Government Contributions$0$0$0
Federal$0$0$0
State$0$0$0
Local$0$0$0
Unspecified$0$0$0
Individual Contributions$83,555$610,208$308,550
$0$0$0
$12,369,819$12,279,958$12,841,019
Investment Income, Net of Losses$99,301$77,073$50,951
Membership Dues$0$0$0
Special Events$71,740$44,416$26,551
Revenue In-Kind$190,769$288,877$271,468
Other$18,563$27,149$25,451
Expense Allocation
Fiscal Year201620152014
Program Expense$11,521,054$12,030,095$12,594,549
Administration Expense$947,081$914,130$888,320
Fundraising Expense$134,787$162,199$75,437
Payments to Affiliates$0$0$0
Total Revenue/Total Expenses1.000.990.98
Program Expense/Total Expenses91%92%93%
Fundraising Expense/Contributed Revenue87%25%23%
Assets and Liabilities
Fiscal Year201620152014
Total Assets$9,539,000$8,885,068$9,210,723
Current Assets$5,933,673$4,845,258$5,200,979
Long-Term Liabilities$0$299,948$179,000
Current Liabilities$1,652,583$927,911$1,125,358
Total Net Assets$7,886,417$7,657,209$7,906,365
Top Funding Sources
Fiscal Year201620152014
Top Funding Source & Dollar AmountProcess and Service Fees $8,258,390Processing and Service Fees $8,098,868Processing and service fees $8,991,935
Second Highest Funding Source & Dollar AmountLaboratory Test Fees $2,322,403Laboratory Test Fees $2,102,696Lab Test Fees $1,978,295
Third Highest Funding Source & Dollar AmountExport Fees $988,707Export Fees $1,292,394Export Fees $1,162,404
CEO/Executive Director Compensation $175,001 - $200,000
Tax Credits No
Solvency
Short Term Solvency
Fiscal Year201620152014
Current Ratio: Current Assets/Current Liabilities3.595.224.62
Long Term Solvency
Fiscal Year201620152014
Long-Term Liabilities/Total Assets0%3%2%
Financials Comments
Financial Comments by Organization

Blood centers are unique among not-for-profit organizations; when operating efficiently, our operating expenses can be covered from fees charged for our products and services.  I am proud to report that SunCoast Blood Bank’s operation is extremely efficient and cost effective. In the rare event of a natural or other disaster, if hospital demand were to exceed SunCoast’s current level of supply, we also maintain funds which would enable us to purchase and import blood products from other parts of country.  Our primary challenge is absorbing the costs of capital equipment.  These purchases are not luxuries.  Rather, they are necessities often mandated by the Federal Drug Administration in order for us to continue to safely collect, manufacture, store, and deliver blood components.  We allocate a significant amount of funds toward capital improvements, however, the mandated and medically advised advancements required often exceed our ability to pay.  Therefore, we rely on the generosity of foundations and individuals to help us remain operational as we strive to maintain a safe and reliable blood supply for our community. 

Scott Bush, CEO 

Financial Comments by Foundation
Financial figures taken from IRS Form 990 and audit documents.  990s and audits are reconciled for 2009 and 2010.  Total liabilities reported in 2008 audit: $776,879.  Individual contributions include foundation and corporate support, as reported on Form 990. In-kind contribution revenue includes non-cash contributions and donated services and use of facilities as reported on the IRS Form 990.  Donated services and facilities are not included in total revenue on the IRS Form 990. 

THE COMMUNITY FOUNDATION OF SARASOTA COUNTY, INC. IS A REGISTERED 501(C)(3) NON-PROFIT CORPORATION. A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE WITHIN THE STATE (1-800-HELP-FLA) OR FROM THE WEBSITE: WWW.FRESHFROMFLORIDA.COM. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE. ONE HUNDRED PERCENT (100%) OF EACH CONTRIBUTION IS RECEIVED BY THE COMMUNITY FOUNDATION OF SARASOTA COUNTY. REGISTRATION #SC-02471.